These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 35722764)

  • 1. Lymphatic targeting for therapeutic application using nanoparticulate systems.
    Singh N; Handa M; Singh V; Kesharwani P; Shukla R
    J Drug Target; 2022 Dec; 30(10):1017-1033. PubMed ID: 35722764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the intestinal lymphatic system: a versatile path for enhanced oral bioavailability of drugs.
    Managuli RS; Raut SY; Reddy MS; Mutalik S
    Expert Opin Drug Deliv; 2018 Aug; 15(8):787-804. PubMed ID: 30025212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphatic Delivery of Anti-HIV Drug Nanoparticles.
    Nayak Y; Avadhani K; Mutalik S; Nayak UY
    Recent Pat Nanotechnol; 2016; 10(2):116-27. PubMed ID: 27502389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanocarriers based novel and effective drug delivery system.
    Khizar S; Alrushaid N; Alam Khan F; Zine N; Jaffrezic-Renault N; Errachid A; Elaissari A
    Int J Pharm; 2023 Feb; 632():122570. PubMed ID: 36587775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphatic Targeting of Nanosystems for Anticancer Drug Therapy.
    Abellan-Pose R; Csaba N; Alonso MJ
    Curr Pharm Des; 2016; 22(9):1194-209. PubMed ID: 26675222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in combination of microneedles and nanomedicines for lymphatic targeted drug delivery.
    Permana AD; Nainu F; Moffatt K; Larrañeta E; Donnelly RF
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 May; 13(3):e1690. PubMed ID: 33401339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer's Disease and its Related Dementia Types: A Review on Their Management
    Siafaka PI; Mutlu G; Okur NÜ
    Curr Alzheimer Res; 2020; 17(14):1239-1261. PubMed ID: 33602090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanotechnology in therapeutics: a focus on nanoparticles as a drug delivery system.
    Bamrungsap S; Zhao Z; Chen T; Wang L; Li C; Fu T; Tan W
    Nanomedicine (Lond); 2012 Aug; 7(8):1253-71. PubMed ID: 22931450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanocarriers.
    Torchilin VP
    Pharm Res; 2007 Dec; 24(12):2333-4. PubMed ID: 17934800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Saccharide modified pharmaceutical nanocarriers for targeted drug and gene delivery.
    Yu W; Zhang N; Li C
    Curr Pharm Des; 2009; 15(32):3826-36. PubMed ID: 19925431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphatic system: a prospective area for advanced targeting of particulate drug carriers.
    Singh I; Swami R; Khan W; Sistla R
    Expert Opin Drug Deliv; 2014 Feb; 11(2):211-29. PubMed ID: 24350774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent trends of nanomedicinal approaches in clinics.
    Dilnawaz F; Acharya S; Sahoo SK
    Int J Pharm; 2018 Mar; 538(1-2):263-278. PubMed ID: 29339248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmaceutical development and regulatory considerations for nanoparticles and nanoparticulate drug delivery systems.
    Narang AS; Chang RK; Hussain MA
    J Pharm Sci; 2013 Nov; 102(11):3867-82. PubMed ID: 24037829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent update of toxicity aspects of nanoparticulate systems for drug delivery.
    Patnaik S; Gorain B; Padhi S; Choudhury H; Gabr GA; Md S; Kumar Mishra D; Kesharwani P
    Eur J Pharm Biopharm; 2021 Apr; 161():100-119. PubMed ID: 33639254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solid lipid nanoparticle-based dissolving microneedles: A promising intradermal lymph targeting drug delivery system with potential for enhanced treatment of lymphatic filariasis.
    Permana AD; Tekko IA; McCrudden MTC; Anjani QK; Ramadon D; McCarthy HO; Donnelly RF
    J Control Release; 2019 Dec; 316():34-52. PubMed ID: 31655132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of the current scientific and regulatory status of nanomedicines and the challenges ahead.
    Hock SC; Ying YM; Wah CL
    PDA J Pharm Sci Technol; 2011; 65(2):177-95. PubMed ID: 21502077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug delivery nanocarriers and recent advances ventured to improve therapeutic efficacy against osteosarcoma: an overview.
    Desai SA; Manjappa A; Khulbe P
    J Egypt Natl Canc Inst; 2021 Feb; 33(1):4. PubMed ID: 33555490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Injectable Drug-Loaded Nanocarriers for Lung Cancer Treatments.
    Yu HP; Aljuffali IA; Fang JY
    Curr Pharm Des; 2017; 23(3):481-494. PubMed ID: 28292243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Organ-restricted delivery through stimuli-responsive nanocarriers for lung cancer therapy.
    Dinakar YH; Karole A; Parvez S; Jain V; Mudavath SL
    Life Sci; 2022 Dec; 310():121133. PubMed ID: 36306866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid-Based Nanocarriers for Lymphatic Transportation.
    Vishwakarma N; Jain A; Sharma R; Mody N; Vyas S; Vyas SP
    AAPS PharmSciTech; 2019 Jan; 20(2):83. PubMed ID: 30673895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.